Atomoxetine may be an effective and safe nonstimulant alternative drug for children and adolescents with attention-deficit/hyperactivity disorder (ADHD), new research hints. "Atomoxetine demonstrates comparable safety and tolerability to stimulant medications and should be considered a valid treatment alternative for those who do not tolerate or respond to stimulants," said lead author Dr. M.M. Naveen, child and adolescent psychiatry fellow in the University of Maryland Sheppard Pratt program in Baltimore.